0000950170-24-128773.txt : 20241220 0000950170-24-128773.hdr.sgml : 20241220 20241119170919 ACCESSION NUMBER: 0000950170-24-128773 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: enGene Holdings Inc. CENTRAL INDEX KEY: 0001980845 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 4868 RUE LEVY, SUITE 220 CITY: SAINT-LAURENT STATE: A8 ZIP: H4R 2P1 BUSINESS PHONE: (514) 332-4888 MAIL ADDRESS: STREET 1: 4868 RUE LEVY, SUITE 220 CITY: SAINT-LAURENT STATE: A8 ZIP: H4R 2P1 CORRESP 1 filename1.htm CORRESP

 

enGene Holdings Inc.

4868 Rue Levy, Suite 220

Saint-Laurent, QC H4R2P1

(514) 332-4888

 

November 19, 2024

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attention: Mr. Chris Edwards

Re: enGene Holdings Inc.

Registration Statement on Form S-3

Filed November 13, 2024

File No. 333-283202

 

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, enGene Holdings Inc. hereby requests acceleration of the effective date of the above-referenced registration statement on Form S-3, so that such registration statement may become effective at 4:00 P.M. (Washington, D.C. time) on November 21, 2024, or as soon as practicable thereafter.

 

The Registrant hereby authorizes Maria L. Sasinoski, of Morgan, Lewis & Bockius LLP to orally modify or withdraw this request for acceleration.

 

Please contact Maria L. Sasinoski of Morgan, Lewis & Bockius LLP at (412) 560-7482 or maria.sasinoski@morganlewis.com with any questions you may have concerning this request, and please notify her when this request for acceleration has been granted.

 

 

enGene Holdings Inc.

 

 

 

By: /s/ Ronald H.W. Cooper

Name: Ronald H.W. Cooper

Title: Chief Executive Officer